Dr. Lal Pathlabs Ltd. Financials: Quarterly Results
Revenue
628.4
Cr.
PAT
155.50
Cr.
EBITDA
158.40
Cr.
Dr. Lal Pathlabs Ltd. Q4FY25 Financial Metrics
| Indicator | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 602.60 | 596.70 | 660.20 | 601.90 | 545.40 |
| Total Income From Operations (Cr.) | 602.60 | 596.70 | 660.20 | 601.90 | 545.40 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 158.40 | 143.60 | 189.10 | 155.90 | 126.50 |
| P/L Before Exceptional Items & Tax (Cr.) | 153.40 | 138.30 | 183.10 | 149.90 | 119.90 |
| P/L After Tax from Ordinary Activities (Cr.) | 155.50 | 98.10 | 130.80 | 107.80 | 85.80 |
| Net Profit/Loss For the Period (Cr.) | 155.50 | 98.10 | 130.80 | 107.80 | 85.80 |
| Basic EPS | 18.57 | 11.60 | 15.52 | 12.79 | 10.13 |
FAQs
Dr. Lal Pathlabs Ltd. announced its quarterly results for Q4 FY2025 on April 25, 2025.
In Q4 FY2025, Dr. Lal Pathlabs Ltd. are as follows:
Revenue: ₹628.4 crore
Net Profit: ₹155.50 crore.
For Q4 FY2025, Dr. Lal Pathlabs Ltd. posted ₹628.4 crore in revenue and ₹155.50 crore in net profit.
Past quarterly results for Dr. Lal Pathlabs Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.